Autopsy report · NCT05986890
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
Cause of deathSlow enrollment
“The study was terminated early due to poor participant accrual, resulting in inadequate enrollment to support the planned analysis and study endpoints.”
Life of this trial
- Ran for about 2 years 11 months before it stopped.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Corewell Health West
- Sponsor type
- University, hospital or other
- Conditions
- Malignant Gastric Outlet Obstruction
- Interventions
- Roux-en-Y Bypass; gastrojejunostomy
- Participants
- 5
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
“This study was terminated due to low participant enrollment.” - A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
“This study was terminated early due to poor enrollment.” - MIRACLE EF Clinical Study
“The study was terminated early due to low enrollment.” - Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
“the study was terminated early due to poor enrollment” - The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
“This study was prematurely terminated due to low enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.